Quarterly Result23 Jul 2025, 03:57 pm
Thyrocare Technologies Ltd Reports Q1FY26 Revenue of INR 193.03 Cr with 23% YoY Growth
AI Summary
Thyrocare Technologies Limited, a leading healthcare diagnostics company, has announced its results for the quarter ended June 30, 2025. The company saw a YoY increase of 23% in consolidated revenue, driven by a 25% growth in Pathology and a 6% growth in Radiology. Pathology Business franchise revenue grew by 20% YoY, while partnership revenue surged by 36% YoY. Total test volume reached 46.9 million in Q1FY26, reflecting a 15% YoY increase. The consolidated gross margin stood at 71%, with reported EBITDA margin at 30%. Consolidated EBITDA grew by 37% YoY, while PAT saw a significant YoY increase of 62%. The company also opened new labs in Bhagalpur, Kashmir, and Roorkee.
Key Highlights
- Consolidated revenue saw a YoY increase of 23%, driven by a 25% growth in Pathology and an 6% growth in Radiology.
- Pathology Business - Franchise revenue grew by 20% YoY, while partnership revenue surged by 36% YoY.
- Total test volume reached 46.9 million in Q1FY26, reflecting a 15% YoY increase.
- Consolidated Gross Margin stood at 71%, with reported EBITDA margin at 30%.
- Consolidated EBITDA grew by 37% YoY, while PAT saw a significant YoY increase of 62%.